Literature DB >> 29429042

The cytotoxicity effects of a novel Cu complex on MCF-7 human breast cancerous cells.

Fatemeh Mohammadizadeh1,2, Soudeh Khanamani Falahati-Pour2, Azadeh Rezaei1,3, Maryam Mohamadi2, Mohammad Reza Hajizadeh1,3, Mohammad Reza Mirzaei1,3, Alireza Khoshdel1,2, Mohammad Ali Fahmidehkar4, Mehdi Mahmoodi5,6.   

Abstract

A variety of biological activities, such as anti-microbial and anti-tumor properties was reported for 1,10-phenanthroline and its copper complexes. In this study, the anti-proliferative activity of a novel  [Cu(L)(phen)] complex was investigated on MCF-7 breast cancer cells using MTT assay. Since chemotherapy is lake of ability to distinguish between normal cells from cancerous cells, therefore we also investigated the effect of  [Cu(L)(phen)] complex on normal L929 cells. The results showed that following 24 and 48 h exposure of cells with  [Cu(L)(phen)] complex, the IC50 values for MCF-7 were significantly lower than that recorded for L929 and normal cells were less sensitive than cancerous cells to the complex. Additionally, the  [Cu(L)(phen)] complex displayed a time- and concentration-dependent cytotoxic response, with MCF-7 and L929 cells. Also flow cytometry findings suggest that  [Cu(L)(phen)] complex is capable of decreasing cancer cell viability through apoptosis and did not efficiently activate the necrosis process.

Entities:  

Keywords:  Apoptosis; Breast cancer; Cytotoxicity; MCF-7 cell line; [Cu(L)(phen)] complex

Mesh:

Substances:

Year:  2018        PMID: 29429042     DOI: 10.1007/s10534-018-0079-5

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  7 in total

1.  Tetramethyl-phenanthroline copper complexes in the development of drugs to treat cancer: synthesis, characterization and cytotoxicity studies of a series of copper(II)-L-dipeptide-3,4,7,8-tetramethyl-phenanthroline complexes.

Authors:  Natalia Alvarez; Celisnolia M Leite; Adriana Napoleone; Luis F S Mendes; Carlos Y Fernández; Ronny R Ribeiro; Javier Ellena; Alzir A Batista; Antonio J Costa-Filho; Gianella Facchin
Journal:  J Biol Inorg Chem       Date:  2022-05-07       Impact factor: 3.862

2.  6-Methoxyquinoline complexes as lung carcinoma agents: induction of oxidative damage on A549 monolayer and multicellular spheroid model.

Authors:  J F Cadavid-Vargas; C Villa-Pérez; M C Ruiz; I E León; G C Valencia-Uribe; D B Soria; S B Etcheverry; A L Di Virgilio
Journal:  J Biol Inorg Chem       Date:  2019-01-30       Impact factor: 3.358

3.  Nisin Induces Cytotoxicity and Apoptosis in Human Asterocytoma Cell Line (SW1088)

Authors:  Nahid Zainodini; Gholamhossein Hassanshahi; Mohammadreza Hajizadeh; Soudeh Khanamani Falahati-Pour; Mehdi Mahmoodi; Mohammad Reza Mirzaei
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

4.  Green synthesis of silver nanoparticles at low temperature in a fast pace with unique DPPH radical scavenging and selective cytotoxicity against MCF-7 and BT-20 tumor cell lines.

Authors:  Sadegh Khorrami; Atefeh Zarepour; Ali Zarrabi
Journal:  Biotechnol Rep (Amst)       Date:  2019-11-09

5.  Vanadium complex: an appropriate candidate for killing hepatocellular carcinoma cancerous cells.

Authors:  Hamid Bakhshi Aliabad; Soudeh Khanamani Falahati-Pour; Hadis Ahmadirad; Maryam Mohamadi; Mohammad Reza Hajizadeh; Mehdi Mahmoodi
Journal:  Biometals       Date:  2018-09-25       Impact factor: 2.949

6.  Effect of a Copper (II) Complex on The Induction of Apoptosis in Human Hepatocellular Carcinoma Cells

Authors:  Azadeh Rezaei; Soudeh Khanamani Falahati-Pour; Fatemeh Mohammadizadeh; Mohammad Reza Hajizadeh; Mohammad Reza Mirzaei; Alireza Khoshdel; Mohammad Ali Fahmidehkar; Mehdi Mahmoodi
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-26

7.  Apoptotic effect of novel pyrazolone-based derivative [Cu(PMPP-SAL)(EtOH)] on HeLa cells and its mechanism.

Authors:  Delizhaer Reheman; Jing Zhao; Shan Guan; Guan-Cheng Xu; Yi-Jie Li; Su-Rong Sun
Journal:  Sci Rep       Date:  2020-10-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.